Abstract / Description of output
Kinetoplastid parasites cause diverse neglected diseases in humans and livestock, with an urgent need for new treatments. Survival of kinetoplastids depends on their uniquely structured mitochondrial genome (kDNA), the eponymous kinetoplast. Here we report development of a high-content screen for pharmacologically induced kDNA loss, based on specific staining of parasites and automated image analysis. As proof-of-concept we screened a diverse set of ∼14,000 small molecules and exemplify a validated hit as a novel kDNA-targeting compound
Original language | English |
---|---|
Journal | Antimicrobial Agents and Chemotherapy |
Early online date | 6 Dec 2021 |
DOIs | |
Publication status | E-pub ahead of print - 6 Dec 2021 |
Keywords / Materials (for Non-textual outputs)
- High-throughput screening
- high-content screening
- trypanosomatids
- kinetoplast
- kDNA
- mitochondia
Fingerprint
Dive into the research topics of 'A novel high-content phenotypic screen to identify inhibitors of mitochondrial DNA maintenance in trypanosomes'. Together they form a unique fingerprint.Equipment
-
Edinburgh Drug Discovery
Asier Unciti-Broceta (Manager), Scott Webster (Manager) & Neil Carragher (Manager)
Deanery of Molecular, Genetic and Population Health SciencesFacility/equipment: Facility